The expression and coefficients of the four selected PCDRGs (SLC39A14, ATP6V1G2, DOCK1, and SORT1) and their transcription levels were used to construct a prognostic risk score for AML patients. The gene discussed is SLC39A14; the disease is acute myeloid leukemia.